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Abstract 
Cytochrome P450 enzymes are important for biotechnology due to their capacity to modify diverse 
secondary metabolites that may produce chemicals with pharmacological properties. Most terpenes, 
flavonoids and alkaloids require P450 catalytic functions to reach their biological activity. In the last ten 
years, several efforts have focused on the expression and production of these three main types of 
secondary metabolites in engineered microorganisms and plants using P450 of ethnobotanical origin. 
Despite this, several P450 coding sequences from plant sources are discovered yearly but only a few 
have been screened by functional genomics. Amongst them, only a few have shown potentials for use 
in sustainable production of novel drugs and highly valuable products. Cytochrome P450 involvement in 
the biosynthesis of these products is discussed in this work. 
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Plant cytochrome P450 enzymes are important in 
biotechnology due to their ability to biosynthesize 
diverse secondary metabolites with biological 
properties. Numerous reports describe the 
application of P450 monoxygenases, 
desaturases and methyl transferases from plants 
as candidates for creating novel varieties of 
modified vegetables and bio-products [1-3].  
P450 DNA coding sequences are also selected 
to originate pharmaceutical products, because of 
their importance as target genes for 
microorganism’s metabolic engineering. Organic 
compounds with therapeutic uses and 
phytopharmaceuticals directly or indirectly 
derived from these enzymes are now recognized 
as critical alternatives for treating different 
illnesses. This is the case of taxol and the 
periwinkle alkaloids, which are widely used in 
cancer therapy [4]. 
 
Bioactive secondary metabolites are routinely 
extracted from the plant itself or produced by 
synthetic-chemistry in order to scale-up their 
production. Nevertheless, the sustainable 
production by those methods is not always 
successful [5]. Sometimes it is compromised 
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because of many features that distress plants 
like, the required phenological stage, the specific 
interactions with biotic and abiotic factors that 
modify their accumulation, as well as difficulties 
in the extraction procedures and all associated 
with high investments [6]. Due to these 
circumstances, many phytopharmaceuticals 
usually do not reach the clinical trials stage or the 
commercial attractive just decline. Currently, 
biotechnological platforms are gaining grounds in 
the sustainable production of pharmacologically 
active metabolites from plants. This alternative is 
not only in accordance with global ecological 
legislation, their implementation is also a 
promising and reliable tool for scaling plant 
metabolites production with complex chemical 
structures [7]. Despite the presence of other key 
enzymes actively involved in the biosynthesis of 
secondary metabolites, P450 are essential in 
almost all pathways of plant natural products. 
They are especially involved in the fine 
modification of the chemical skeletons originated 
by diverse synthases. In this review, we present 
relevant approaches in the production of 
promising pharmacological metabolites through 
molecular biotechnology using plant P450 
enzymes in microorganisms and other plants.  
 
GENETIC ENGINEERING OF P450 





Up to now, six sesquiterpenes have been 
successfully produced in heterologous systems 
by using P450 coding sequences (Figure 1).  The 
anti-malarial drug, artemisinin (1) is a 
sesquiterpene lactone biosynthesized by 
Artemisia spp. It is used as a precursor of 
artemether which when combined with 
lumefantrine results in an exceptional drug 
against the tropical disease called Coartem ® by 
Novartis. As in many secondary metabolites, 
artemisinin is present in small quantities in the 
plant itself, thus limiting its extraction for 
therapeutic aims. Among first remarkable results 
on artemisinic acid production was by 
engineered Saccharomyces cerevisiae yielding 
over 100 mg L-1 [8].  
 
A recent report described the optimization of 
artemisinic acid biosynthesis in S. cerevisiae by 
the insertion of distinct DNA coding sequences 
isolated from A. annua such as cytochrome b5 
(CYB5), an artemisinic aldehyde dehydrogenase 
(ALDH1), an alcohol dehydrogenase (ADH) and 
the CYP71AV1 genes [9]. The newly engineered 
yeast strains generated in this work were able to 
synthetize artemisinic acid in the order of 25 g L-1 
when GAL promoters were induced to express 
the recombinant proteins. Therefore, artemisinic 
acid yields were increased ~250 times compared 
to the first attempt. The same report also 
describes an easy method for the chemical 
synthesis of artemisinin [9]. Orthologs of 
CYP71AV1 gene were reported for several 
Artemisia species revealing polymorphisms that 
could influence the transformation of amorpha-4, 
11-diene to artemisinic acid [10]. To date, 
engineered strains that actively biosynthesize 
artemisinic acid seem to be an attractive, 
cheaper and effective choice for industrializing 
the artemisinin production and also to decrease 
costs of the anti-malarial medicines in the short 
term. 
 
Nootkatone is a sesquiterpene and the main 
natural and expensive substance of the smell 
and flavor of grapefruit. Nootkatone is also an 
effective and environmentally friendly 
repellent/insecticide against mosquitos, bed 
bugs, head lice and other insects [11]. It is non-
toxic to humans and is an approved food additive 






                  Figure 1: Some sesquiterpenes derived from P450 enzyme activity 
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Currently, flavor and fragrances are extracted 
from the oil of fruit peels to be used in drinks and 
perfumes. However and because supply of these 
fruits is limited and have a low amount of these 
substances, the price of nootkatone is around $ 
2,000 a pound and the valencene (4) sells for $ 
600 a pound or more [12]. Allylix (San Diego, 
CA) developed a fermentation process to 
produce nootkatone after engineering baker’s 
yeast to produce a variety of smells and flavors 
[12].  
 
The current knowledge of metabolic pathways of 
valencene and other sesquiterpenes like 
capsidiol (3), a bicyclic sesquiterpenic 
phytoalexin from Capsicum and Nicotiana plants 
[13]; is now used. The genes of 5-epi-
aristolochene synthase and the valencene 
synthase enzymes (both with N-terminal 
thioredoxin modification) in combination with the 
5-epi-aristolochene dihydroxylase (CYP71D20); 
all were inserted and differentially expressed in a 
specific yeast strain (EPY300). The transgenic 
organism was able to produce ~250 mg L-1 
capsidiol and small quantities of valencene [14]. 
This improved the production of the phytoalexin 
in a heterologous system without the need of 
adding exogenous precursors.  
 
Solavetivone (2) is an antifungal phytoalexin 
derived from a vetispirane-type sesquiterpene 
premnaspirodiene synthesized by Hyoscyamus 
muticus. Premnaspirodiene oxidase (HPO-
CYP71D55) enzyme seems to be involved in the 
double oxidation of solavetivone and other 
vetispirane precursors, showing a multisusbtrate 
but very valuable activity [15].  
 
Costunolide (5) is a germacranolide 
sesquiterpene lactone that shows potent anti-
proliferative properties in different types of 
cancer [16]. Costunolide is also considered the 
precursor of many sesquiterpene lactones with 
significant biological activities [17]. Expressed 
sequence tag (EST) sets from Nicotiana 
benthamiana led to the isolation of germacrene A 
synthase (GAS), germacrene A oxidase (GAO) 
and the recently characterized chicory 
costunolide synthase (CiCos, CYP71BL3) genes. 
These were co-expressed in S. cerevisiae WAT 
11 strain to produce low yields of costunolide 
[17]. Costic acid is a related sesquiterpene 
carboxylic acid that shows an interesting 
cytotoxic activity against several phytopathogenic 
fungi [18]. The functional characterization and 
expression of germacrene A synthase/ 
germacrene A oxidase (TcGAS/TcGAO, 
CYP71AV2) and costunolide synthase (TcCOS) 
genes from Tanacetum cinerariifolium in yeast 
(WAT11), resulted in the production of α (6) and 
γ (7) costic acid isomers [19].  
 
Zerumbone (8) is a humulene derivative with 
anti-inflammatory, anti-HIV and potent anti-
tumoral properties that is abundant in Zingiber 
zerumbet. Zerumbone biosynthesis includes the 
generation of the 8-hydroxy-α-humulene 
intermediate. Recent studies revealed that 
CYP71BA1 is the key enzyme involved in the 
biosynthesis of this molecule in accordance with 
its heterologous expression in yeast [20]. Co-
expression of four genes from the mevalonate 
pathway including CYP71BA1 and ZSS1 in 
Escherichia coli, were able to produce small 
yields of 8-hydroxy-α-humulene [20].  
 
These novel methods promise a major control on 
the biochemical synthesis of natural substances 
avoiding complex protocols for its induction and 
direct extraction from plant tissues. Table 1 
describes the use of selected P450 for producing 





Some tricyclic and tetracyclic diterpenes 
produced by P450 enzyme activity are shown in 
Figure 2. Kaurenoic acid (9) is one of the most 
studied diterpenes with a wide range of biological 
activities [21]. Beyond the known participation of 
ent-kaurene oxidases (KO´s) 
 
 
         Table 1: Bioactive sesquiterpenes produced in heterologous systems using P450 from plant sources 
 
P450* Source Bioactive product Reference 
CYP71AV1Y Artemisia annua Artemisinin [8,9] 
CYP71D55Y Hyoscyamus muticus Solavetivone [15] 
CYP71D20Y Nicotiana tabacum Capsidiol [14] 
CYP71BL3Y Nicotiana benthamiana Costunolide [17] 
CYP71BA1YB Zingiber zerumbet Zerumbone [20] 
CYP71AV2Y Tanacetum cinerariifolium Costic Acid isomers [19] 
*P450 genes involved in the biosynthesis of the bioactive product but not necessarily in the final step. 
Superscripts correspond to their expression in yeast (Y) or bacterial (B) systems, respectively 
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from plants in gibberellin biosynthesis, current 
approaches highlight the potential uses of this 
family of P450 enzymes in several 
biotechnological areas. The records of the 
National Center for Biotechnology Information 
(NCBI) reveal at least 30 putative KO´s 
nucleotide sequences. However, the 
Braunschweig Enzyme Database (BRENDA) 
reveals that only about 17 % of those sequences 
have been biochemically characterized so far.  
 
The non-sugar sweeteners global market was 
calculated to rise from $ 9.2 billion in 2010 up to 
US$ 9.9 billion in 2016 [22]. Considering the 
commercial importance of this market, the source 
for new procedures to get these products was 
also elicited. Stevia is a sweetener and sugar 
substitute extracted from the leaves of Stevia 
rebaudiana. The reconstruction of the steviol 
metabolic pathway in yeast, including the 
expression of a fungal KO and the ent-kaurenoic 
acid 13-hydroxylase (KA-13-H) genes is currently 
protected by a patent due to the commercial 
interest in the controlled production of natural 
glucosides [23]. Genetic engineering for steviol 
glycosides in yeast is considered a reliable 
option that may contribute to the optimization of 
this non-caloric sweetener for industrial aims. 
This new technology will change the 
perspectives on stevioside production because of 
their ecological advantages. 
 
Novel KO-cDNA sequences from medicinal or 
agronomic plants, such as Montanoa tomentosa 
(MtKO), Momordica charantia (McEKO), 
Cucumis sativus (CKO) and the moss 
Physcomitrella patens (CYP701B1); were 
recently reported [24-27]. However, only 
CYP701B1 and MtKO (CYP701A-type) were 
expressed in yeast and characterized at 
biochemical level, the respective enzymes 
showed resistance to relative high concentrations 
of azolic compounds [26,28]. This characteristic 
could further be used in metabolic engineering 
procedures. The apparent kinetic parameters of 
MtKO enzyme are also interesting considering 
that the high value of Km app supports aputative 
multisubstrate activity [28]. 
  
Genetic engineering of ent-kaurene and ent-
kaurenoic acid in yeast was improved by using 
known KO enzymes from Gibberella fujikuroi and 
Arabidopsis thaliana [29]. The engineered yeasts 
containing these recombinant enzymes yield at 
least 0.5 grams L-1 of ent-kaurenoic acid in fed 
batch fermentation conditions. Deletions, peptide 
additions and codon optimization at the 5’ end 
(N-terminal end) of the AtKO1 gene from A. 
thaliana confer favorable changes in its specific 
activity [30]. These modifications have 
contributed to the expression of this P450 in 
relatively low-cost sustainable microorganisms 
such as Escherichia coli. In addition, these 
studies also show that KO possesses 
multifunctional activity on ent-beyerene and 
isokaurene skeletons. Further studies on the 
biochemistry of KO´s from medicinal plants that 
actively biosynthesize tetracyclic diterpenoids, 
could reveal interesting enzymatic properties for 
biotechnology use.  
 
Abietadiene diterpenes present mainly in resins 
from conifers commonly show insecticide, 
allelopathic and antifungal effects [31]. 
Expression of the multifunctional and 
multisubstrate CYP720B1 gene from Pinus taeda 
in yeast, demonstrates its capability for 
metabolizing abietadiene (10) and 
levopimaradiene (11) skeletons to originate 
oxygenated diterpenes associated with chemical 
defense [32]. The expression of CYP720B4 gene 
from Picea sitchensis in the same system, also 
demonstrated its effectiveness in the oxidation of 
C-18 in several abietadienes, levopimaridienes 





      Figure 2: Some diterpenes derived from P450 enzyme activity 
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Table 2: Bioactive diterpenes produced in heterologous systems by using P450 from plant sources 
 
P450* Source  Bioactive product Reference 






CYP701B1Y Physcomitrella patens ent-kaurenoic acid [26] 







CYP72-type Y Stevia rebaudiana 
Steviosides and 
rebaudiosides [23] 
CYP76AH1Y Salvia miltiorrhiza Ferruginol [33] 
CYP701A-typeY Montanoa tomentosa ent-kaurenoic acid [28] 
*P450 involved in the biosynthesis of the bioactive product but not necessarily in the final step. Superscripts 
correspond to their expression in yeast (Y) 
 
turning alcoholic into carboxylic acid forms [31]. 
The unusual multisubstrate activity of this 
enzyme reveals potential uses in pharmacology. 
  
Ferruginol (13), an abietane diterpene 
(meroterpene type) with gastro-protective and 
anti-tumoral activities, has been produced at a 
yield of 10.5 mg L-1 in transformed WAT11 strain 
(S. cerevisiae) containing CYP76AH1 from 
Salvia miltiorrhiza and phyto-CYP reductase 
genes [33]. The discovery of this enzyme and its 
participation in tanshinone biosynthesis could be 
a relevant contribution to the elucidation of the 
biosynthetic pathway of carnosic acid, a 
pharmacologically active metabolite and also a 
chemotaxonomic marker of the Salvia genus. 
Yeast expression of P450 involved in abietane 
and piamarane type diterpenes represents the 
first approach for the generation of novel 
platforms for the diterpene resin acids controlled 
production.  Table 2 shows recent P450 





Production of triterpenes with potential use in 
pharmacology has been improved in the last 
years (Figure 3). Initial attempts to clone P450 
sequences involved in triterpene biosynthesis 
were carried out in Glycine max, with the 
identification of CYP93E1 and heterologous gene 
expression in yeast. According to these studies 
β-amyrin and sophoradiol were transformed into 
olean-12-ene-3β-24-diol (14) and soyasapogenol 
B (15). Co-expression of CYP93E1 and β-amyrin 
synthase genes from this plant in the S. 
cerevisiae system showed small yields of olean-
12-ene-3β-24-diol [34]. 
 
Glycyrrhizin (16) is a triterpene glycoside 
sweetener biosynthesized by Glycyrrhiza spp. 
(licorice plants). Expression in yeast of CYP88D6 
gene from an EST bank of these plants showed 
its participation in the modification of β-amyrin 
into 11-oxo-β-amyrin, a putative intermediate in 
glycyrrhizin biosynthesis [35]. Subsequent 
studies revealed that CYP72A154 enzyme, was 
able to oxidize 11-oxo-β-amyrin into 
glycyrrhetinic acid, which is a glycyrrhizin 
aglycone [36]. 
 
Medicago truncatula is a Mediterranean 
medicinal plant that actively produces hemolytic 
saponins. First biochemical studies of 
CYP716A12 gene from this plant revealed its 
capacity for transforming β-amyrin and 
erythrodiol into oleanolic acid (17), a bioactive 
triterpene with hepatoprotective, antitumor and 
antiviral properties [37]. Interestingly, 
simultaneous studies confirmed that CYP716A12 
protein is a multifunctional enzyme able to 
produce ursolic acid (18) and betulinic acid (19) 
after expressed in yeast (INVSc1). Homologs of 
CYP716A12 such as CYP716A15 and 
CYP716A17 from Vitis vinifera exhibited similar 
activities like CYP716A12 [38].  
 
Research on ginsenoside biosynthesis (Panax 
ginseng) reveal specific P450 enzymes involved 
in the addition of the aglycone portion of such 
molecules. The oxidation of dammarenediol-II at 
the C-12 position to protopanaxadiol (20) by 
CYP716A47 in the yeast strain WAT21 was 
reported [39]. Subsequent findings revealed that 
CYP716A53v2 had the protopanaxadiol 6-
hydroxylase enzyme activity. This one produces 
protopanaxatriol (21) from the final aglycone 
protopanaxadiol, which is posteriorly 
glycosylated to several ginsenosides [40]. 
Recently, CYP716A52v2 was functionally 
characterized as a β-amyrin 28-oxydase involved 
in the biosynthesis of oleanane type 
ginsenosides [41].  
Villa-Ruano et al 





                    Figure 3: Some triterpenes derived from P450 enzyme activity 
 
Table 3: Bioactive triterpenes produced in heterologous systems using P450 from plant sources 
 
P450* Source Bioactive product Reference 
CYP93E1Y Glycine max Olean-12-ene-3β-24-diol Soyasapogenol B, [34] 
CYP88D6Y Glycyrrhiza spp. 11-oxo-β-amyrin [35] 
CYP72A154Y Glycyrrhiza spp. Glycyrrhetinic acid [36] 
CYP716A12Y Medicago truncatula Oleanolic acid, Ursolic acid Betulinic acid [37, 38] 
CYP716A15Y Vitis vinifera Ursolic acid Betulinic acid [38] 
CYP716A17Y Vitis vinifera Ursolic acid [38] 
CYP716A47Y Panax ginseng Protopanaxadiol [39] 
CYP716A53v2Y Panax ginseng Protopanaxatriol [40] 
CYP716A52v2Y Panax ginseng Oleanane type ginsenosides [41] 
GLCYP450Y Ganoderma lucidum Ganoderic acids [43] 
 *P450 involved in the biosynthesis of the bioactive product but not necessarily in the final step. Superscripts 
correspond to their expression in yeast (Y) 
 
Ganoderma lucidum, the millenary oriental 
fungus with medicinal and nutritional properties, 
biosynthesize ganoderic acid A (22) that shows a 
potent antioxidant activity [42]. Recent studies 
reported a GLCYP450 as a P450 probably 
involved in the biosynthesis of ganoderic acids 
[43]. Table 3 shows recent P450 enzymes used 
for producing triterpenes with biological activity. 
 
GENETIC ENGINERING OF P450 
INVOLVED IN FLAVONOID 
BIOSYNTHESIS 
 
Some flavonoids with nutraceutical or 
pharmacological properties were produced in 
heterologous systems by using P450 coding 
sequences (Figure 4).  Hydroxylation process is 
critical for flavonoids with dynamic activity. 
Significant efforts to produce flavanones in S. 
cerevisiae have been carried out [44]. Starting 
from natural precursors such as p-coumaric acid, 
cinnamic acid and caffeic acid, a yield of 28.3 mg 
L-1 naringerin (23), 16.3 mg L-1 pinocembrin (24) 
and 6.5 mg L-1 eriodictyol (25) respectively were 
obtained. In these findings naringerin and 
pinocembrin were produced 62 and 22 times 
more efficiently respect to previous attempts in 
prokaryotic cells. 
  
The reconstruction of anthocyanin pathway 
inside E. coli has also been achieved [45]. The 
gene cluster used for this aim included the 
flavonoid 3’ hydroxylase (F3H-P450) 
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anthocyanidin synthase (ANS) from Malus 
domestica and the flavonoid 3-O-
glucosyltransferase from Petunia hybrida. Similar 
attempts to yield phenylpropanoids by using 
exogenous precursors and basic cDNA 
sequences for enzymes involved in flavonoid 
biosynthesis were posteriorly carried out in both 
E. coli and S. cerevisiae [46,47]. In these works 
the participation of flavonoid-3-hydroxylase 
(F3’H) and flavonoid-3-5-dihydroxylase (F3’5’H) 
displayed an essential role in the generation of 
the novel strains specialized in the production of 
flavonoids. Today F3’H and F3’5’H are key 
enzymes used in bringing about pigmentation 
changes in flowers and fruits in order to enhance 
their nutraceutical properties [48]. 
 
Leonard et al reported an interesting approach in 
engineered E. coli for the production of 
kaempferol (26) and quercetin (27), which are 
potent antioxidants and anti-obesity 
phenylpropanoids [49,50]. This attempt was 
carried out by reconstructing the basic flavonoid 
pathway which included the hydroxylating activity 
of flavonoid 3-β-hydroxylase from Malus 
domestica (MdFTH) and F3’5’H from 
Catharanthus roseus. The authors subsequently 
reported a significant improvement in flavonoid 
production by the insertion and overexpression of 
the very active acetyl-CoA carboxylase (PlACC) 
from Photoharbdus luminicens [51].  
 
Vannelli et al described the production of p-
hydroxycinnamic acid (28) from glucose in yeast 
[52]. The novel strain was achieved by using 
both phenylalanine and tyrosine ammonia lyases 
(PAL, TAL) genes from the fungus Rhodotorula 
glutinis. Both were simultaneously expressed 
with cinnamate-4-hydroxylase (C4H-P450 
monooxygenase) and P450 CYP reductase 
genes from Helianthus tuberosus. Improvements 
in the production of p-hydroxycinnamic acid (up 
to 700 mg L-1) were reached in Streptomyces 
lividans using TAL and an endoglucanase from 
Rhodobacter sphaeroides [53].  Despite the latter 
advances, current engineered microorganisms 
for producing hydroxylated flavonoids require 
exogenous precursors to generate them. 
Therefore, a great challenge for flavonoid genetic 
engineering is to get self-sufficient 
microorganisms able to produce those 
metabolites without the addition of external 
intermediates. This condition has only been 
successfully achieved for relatively simple 
stilbene flavonoids such as resveratrol (29) in 
transgenic E. coli strains [54]. Table 4 shows 
some conserved P450 monooxygenases used 





                             Figure 4: Some flavonoids derived from P450 enzyme activity 
 
Table 4: Bioactive flavonoids produced in heterologous systems using P450 from plant sources 
 
P450* Source Bioactive product Reference 
F3’H-CYP75B-typeYB Malus domestica Flavonones [44-47] 
F3’5’H-CYP75A8B Catharanthus roseus Kaempferol, Quercetin [49] 
C4H-CYP73A1Y Helianthus tuberosus p-hydroxycinnamic acid [52] 
*P450 involved in the biosynthesis of the bioactive product but not necessarily in the final step. Superscripts 
correspond to their expression in yeast (Y) and bacteria (B) 
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GENETIC ENGINEERING OF P450 
ENZYMES INVOLVED IN ALKALOID 
BIOSYNTHESIS 
 
Advances in the synthesis of pharmacologically 
active alkaloids by genetic engineering have 
been reported (Figure 5). Hyoscyamus niger 
commonly known as blackhenbane, is an 
European and North American medicinal plant 
that biosynthesizes high concentrations of 
tropane alkaloids such as hyoscyamine (30). Li 
et al demonstrated the participation of CYP80F1 
in the rearrangement of (R)-littorine to (S)-
hyoscyamine aldehyde, an intermediary in the 
biosynthesis of hyoscyamine [55].  Novel insights 
describe that CYP80F1 catalyzes the 
isomerization and hydroxylation of littorine at the 
3′-position [56]. CYP719B1 gene was isolated 
from Papaver somniferum and showed a 
salutaridine synthase identity. This enzyme 
catalyzes the conversion of (R)-reticuline to 
salutaridine (31), a crucial step in morphine 
biosynthesis [57]. Due to the medical importance 
of morphine (32), a specific transgenic opium 
poppy line was obtained by the insertion of 
CYP80B3 ((S)-N-methylcoclaurine 3’-
hydroxylase) gene, their over-expression 
resulted in > 400 % increase of the total alkaloid 
content in the plant [58]. 
CYP80G2 enzyme from Coptis japonica (hilo de 
oro japonés) catalyzes the C-C phenol for 
producing (S)-corytuberine (33) from (S) 
reticuline, The latter compound is a key 
precursor involved in morphinans, aporphines, 
pavines, protoberberines, protopines and 
benzophenanthiridines [59]. The golden poppy 
(Eschscholzia californica) is a Papaveraceae that 
actively grows in California (USA) and Baja 
California (México). The metabolism of this plant 
is meanly channeled to the biosynthesis of 
isoquinoline alkaloids. The yeast expression of 
CYP719A5 gene showed its role as 
cheilanthifoline (34) synthase whereas 
CYP719A9 enzyme catalyzed the 
methylenedioxy bridge of (R,S)- reticuline (35) 
[60].  
 
Catharanthus roseus is considered the sole 
source of terpene-indole alkaloids for anti-
tumoral therapy. According to novel evidence, 
the multifunctional CYP71BJ1 enzyme is directly 
involved in the steroselective C19 hydroxylation 
of tabersonine (36), lochnericine (37) and 
vincadiformine (38) [61].  Table 5 shows recent 






                          Figure 4: Some alkaloids derived from P450 enzyme activity 
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             Table 5: Bioactive alkaloids produced in heterologous systems using P450 from plant sources 
 
P450* Source Bioactive product Reference 
CYP80F1Y Hyoscyamus niger Hyoscyamine [55] 
CYP80B3P Papaver somniferum Morphine derivatives [58] 
CYP80G2Y Coptis japonica (S)-corytuberine [59] 
CYP719A5Y Eschscholzia californica Cheilanthifoline [60] 
CYP719A9Y Eschscholzia californica (R,S)- reticuline [60] 
CYP719B1Y Papaver somniferum Salutaridine [57] 
CYP71BJ1Y Catharanthus roseus Tabersonine, Lochnericine Vincadiformine [61] 
*P450 involved in the biosynthesis of the bioactive product but not necessarily in the final step. Superscripts 




Biotechnological platforms have shown a 
significant advance in the past few years, 
especially in the synthesis of terpenes in 
heterologous systems. This undoubtedly 
demonstrates the potential uses of P450 
enzymes as key steps for creating novel 
microorganisms that actively produce high 
amounts of plant natural products in a short time. 
This condition should help to reduce the cost of 
pharmaceuticals for treating public health 
problems. Up to date, the artemisinin production 
in engineered yeasts is the most concrete 
example of success in the heterologous 
production of terpenes [9]. Yeast is the preferred 
model for the induction of microsomal P450. 
However, genetic engineering of the amino-
terminus have currently revealed promising 
results for expressing this group of enzymes in 
more reliable microorganisms as E. coli [30]. The 
number of P450 coding enzymes for triterpene 
biosynthesis has particularly increased in the last 
nine years. EST technology has significantly 
contributed to the availability of unique 
sequences from medicinal plant resources 
supporting the discovery of novel P450 with 
pharmacological potential.  
 
Substantial advances have been achieved in the 
production of relatively simple flavonoids as the 
case of resveratrol (3,5,4’-trihydroxy-trans-
stilbene) in E. coli [54]. Conversely, in many 
cases the microbial synthesis of hydroxylated 
flavonoids with a complex structure still depends 
on exogenous precursors to get enough yields.   
 
Production of alkaloids and pseudo alkaloids in 
heterologous systems is another big challenge 
for synthetic biology, considering the exceptional 
reactions that they carry out and their diversity in 
the plant kingdom [3]. It is probable that 
functional genomics for alkaloid production is in 
full swing due to the recent studies validating 
their high scale production in genetically modified 
microorganisms as E. coli and S. cerevisiae [62]. 
Role of cytochrome P450 enzymes in alkaloids 
biosynthesis are quite specific compared with 
those involved in the biosynthesis of flavonoids 
and terpenes. Nonetheless, there are fascinating 
advances in the generation of transgenic lines of 
opium poppy for producing benzylisoquinoline 
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